Skip to the page

Data / Drug companies / Willow Birch Pharma, LLC

Willow Birch Pharma, LLC: 150 products in the FDA NDC directory, labeler code 10695

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Willow Birch Pharma, LLC (labeler code 10695) lists 150 products in the FDA National Drug Code Directory. By type: 148 bulk ingredients, 2 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on October 21, 2026.

The request: Watch Willow Birch Pharma, LLC (FDA labeler code 10695): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
10695
Products in commercial distribution
150
Packages
150
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule IV 3
Started marketing in the last 12 months
39
Earliest marketing start
March 30, 2016
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients8154%
Bulk ingredients for compounding6744.7%
Drugs for further processing21.3%

Products by type

TypeProductsShare
Bulk ingredients14898.7%
Drugs for further processing21.3%

Dosage forms

Dosage formProductsShare
Powder14496%
Crystal32%
Gel21.3%
Syrup10.7%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Mometasone furoate10695-343PowderBulk ingredientsOctober 21, 2026
Sotalol hydrochloride10695-350PowderBulk ingredientsOctober 13, 2026
Atomoxetine hydrochloride10695-348PowderBulk ingredientsOctober 6, 2026
Tadalafilusp10695-175PowderBulk ingredientsOctober 6, 2026
Tadalafilusp10695-175PowderBulk ingredientsOctober 6, 2026
Modafinil10695-347PowderBulk ingredientsSeptember 28, 2026
Oxytocin10695-346PowderBulk ingredientsSeptember 28, 2026
Oxytocin10695-346PowderBulk ingredientsSeptember 28, 2026
Modafinil10695-322PowderBulk ingredientsSeptember 25, 2026
Modafinil10695-322PowderBulk ingredientsSeptember 24, 2026
Hydroxocobalamin10695-341PowderBulk ingredientsSeptember 9, 2026
Levocarnitine10695-333PowderBulk ingredientsSeptember 2, 2026
Trisodium citrate dihydrate10695-321PowderBulk ingredientsSeptember 2, 2026
Fluoxetine10695-173PowderBulk ingredientsAugust 6, 2026
Ezetimibe10695-318PowderBulk ingredientsJuly 29, 2026
Ketoconazole10695-304PowderBulk ingredientsJuly 29, 2026
Rosuvastatin calcium10695-337PowderBulk ingredientsJune 18, 2026
Cyclophosphamide10695-340PowderBulk ingredientsJune 12, 2026
Calcium chloride dihydrate10695-339CrystalBulk ingredients for compoundingJune 11, 2026
Trisodium citrate dihydrate10695-338PowderBulk ingredients for compoundingJune 11, 2026
Rosuvastatin calcium10695-337PowderBulk ingredients for compoundingMay 4, 2026
Methionine10695-336PowderBulk ingredients for compoundingFebruary 10, 2026
Choline chloride10695-335PowderBulk ingredients for compoundingFebruary 10, 2026
Choline chloride10695-335PowderBulk ingredients for compoundingFebruary 10, 2026
Pyridoxine hydrochloride10695-334PowderBulk ingredients for compoundingFebruary 10, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.